Research Contributors: Lori Klein, Rudiger Papsch, Hyein Grace Lee, and Elisabeth Mah
This is a preview of our latest whitepaper. Be sure to download the full piece below.
Medical Affairs teams often struggle to demonstrate their full strategic value by relying heavily on activity-based metrics rather than outcomes-oriented impact metrics.
Leveraging Putnam’s extensive experience with biopharmaceutical clients, this white paper provides practical, actionable guidance to help Medical Affairs leaders select, implement, and communicate impactful metrics. We present a pragmatic framework that enables Medical Affairs teams to position themselves as strategic drivers of patient outcomes, healthcare improvements, and overall organizational success, and ensure readiness for the era of Precision Medical Affairs.
To speak with our experts, fill out the form below.
Jump to a slide with the slide dots.
China is emerging as a global oncology innovation hub, reshaping clinical development, dealmaking, and advanced therapy sourcing worldwide.
Read moreAI is rapidly transforming how healthcare professionals discover, interpret, and trust scientific evidence. Tools such as ChatGPT, OpenEvidence, and G
Read moreDiscover how patient-centric insights boost HCP engagement and commercial impact in this 30-minute session with experts from Research Partnership and
Read more